[The effects of indomethacin and verapamil on dextran-induced shock in rats].
To clarify the mechanism of the anti-shock effect of indomethacin, dextran-induced shock in rats was used as a shock model and compared with the effect of verapamil, a calcium antagonist. Thirty minutes after pretreatment with indomethacin or verapamil, 5% dextran (1 ml/kg body weight) was iv. infused into rats. Pretreatment with indomethacin (5 mg/kg iv.) or verapamil (2 mg/kg iv.) 30 min prior to the dextran infusion prevented significantly a decrease in blood and pulse pressure, and also an increase in the hematocrit value, paw thickness and serum histamine level of rats. Neither pretreatment with indomethacin (or verapamil) nor saline control changed the serum prostaglandin E level before and after the dextran infusion. The effects of verapamil in preventing dextran-induced shock were found to be much greater than those of indomethacin. These results indicated that the shock-preventing effect of indomethacin may be ascribed, at least to some degree, to the role of the drug as a calcium antagonist like verapamil rather than as a cyclooxygenase inhibitor which lowers prostaglandins and/or thromboxane levels. The former effect may be exerted on the mast cells to inhibit calcium influx stimulated by dextran, resulting in the prevention of histamine release.
Ishizaki
M
M
D000818:Animals; D003911:Dextrans; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012772:Shock, Septic / Q000139:chemically induced / Q000188:drug therapy*; D014700:Verapamil / Q000627:therapeutic use*
D003911:Dextrans; D014700:Verapamil; D007213:Indomethacin